---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-013240"
form_type: "8-K"
ticker: "TELO"
cik: "0001971532"
company_name: "Telomir Pharmaceuticals, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:42:52.761077+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# TELO shareholders approve acquisition of Teli Pharma and increase share reserve to 11.5M

## Summary
- Acquisition of Teli Pharmaceuticals approved; issuance of >20% new shares authorized.
- 2023 Omnibus Incentive Plan amended: share reserve increased from 6.5M to 11.5M shares and repricing allowed.
- Bylaws amended to reduce quorum requirement to one-third of outstanding shares.
- Directors elected: Erez Aminov, Matthew Whalen, Edward MacPherson, Matthew Del Giudice.
- Ratification of Salberg & Company as independent auditor for FY 2025 approved.

## SEC filing metadata
- accession: 0001493152-26-013240
- form_type: 8-K
- ticker: TELO
- cik: 0001971532
- company_name: Telomir Pharmaceuticals, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971532/000149315226013240/0001493152-26-013240-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971532/000149315226013240/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-013240
- JSON: https://secwatch.observer/filing/0001493152-26-013240.json
- Plain text: https://secwatch.observer/filing/0001493152-26-013240.txt

## Key facts
- Governance Changes
  Telomir Pharmaceuticals, Inc.: Reduced quorum requirement for shareholder meetings to one-third (effective 2026-03-23).
  - Change: bylaw amendment
  - Effective: 2026-03-23
  source text: the Company’s shareholders approved an amendment to the Bylaws of the Company to reduce the amount required for a quorum for an action by the Company’s shareholders adopted in a meeting to one-third.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971532/000149315226013240/0001493152-26-013240-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
